BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ, Cao X, Lu L. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol. 2010;184:3321-3325. [PMID: 20208006 DOI: 10.4049/jimmunol.0902551] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 14.9] [Reference Citation Analysis]
Number Citing Articles
1 Kim Y, Liu X, Tanaka S, Tran D, Chung Y. Regulation of Germinal Center Reactions by B and T Cells. Antibodies 2013;2:554-86. [DOI: 10.3390/antib2040554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Ponnuswamy P, Joffre J, Herbin O, Esposito B, Laurans L, Binder CJ, Tedder TF, Zeboudj L, Loyer X, Giraud A, Zhang Y, Tedgui A, Mallat Z, Ait-Oufella H. Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells. Sci Rep 2017;7:4111. [PMID: 28646220 DOI: 10.1038/s41598-017-04438-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
3 Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2020;24:1135-45. [PMID: 32900236 DOI: 10.1080/14728222.2020.1821647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zeng SG, Ghnewa YG, O'Reilly VP, Lyons VG, Atzberger A, Hogan AE, Exley MA, Doherty DG. Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro. J Immunol 2013;191:1666-76. [PMID: 23851681 DOI: 10.4049/jimmunol.1202223] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
5 Li W, Tian X, Lu X, Peng Q, Shu X, Yang H, Li Y, Wang Y, Zhang X, Liu Q, Wang G. Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis. Sci Rep 2016;6:27479. [PMID: 27270362 DOI: 10.1038/srep27479] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
6 León B, Ballesteros-Tato A, Misra RS, Wojciechowski W, Lund FE. Unraveling effector functions of B cells during infection: the hidden world beyond antibody production. Infect Disord Drug Targets 2012;12:213-21. [PMID: 22394173 DOI: 10.2174/187152612800564437] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bitoun S, Nocturne G, Ly B, Krzysiek R, Roques P, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Hacein-Bey-Abina S, Mackay F, Pallardy M, Le Grand R, Mariette X. Methotrexate and BAFF interaction prevents immunization against TNF inhibitors. Ann Rheum Dis 2018;77:1463-70. [PMID: 29936438 DOI: 10.1136/annrheumdis-2018-213403] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhang Y, Li J, Zhou N, Zhang Y, Wu M, Xu J, Shen C, An X, Shen G, Yang M, Zhang C, Tao J. The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFcγRIIbhi Regulatory B-Cell Subset in Lupus. Journal of Investigative Dermatology 2017;137:2532-43. [DOI: 10.1016/j.jid.2017.07.843] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
9 Nguyen TG, Morris JM. Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo. Immunology Letters 2014;161:157-64. [DOI: 10.1016/j.imlet.2014.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
10 Ntellas P, Dardiotis E, Sevdali E, Siokas V, Aloizou AM, Tsinti G, Germenis AE, Hadjigeorgiou GM, Eibel H, Speletas M. TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis. Mult Scler Relat Disord 2020;37:101422. [PMID: 32172995 DOI: 10.1016/j.msard.2019.101422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Maerz JK, Trostel C, Lange A, Parusel R, Michaelis L, Schäfer A, Yao H, Löw HC, Frick JS. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses. Front Immunol 2019;10:3093. [PMID: 32038631 DOI: 10.3389/fimmu.2019.03093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
12 Zhang J, Lapato A, Bodhankar S, Vandenbark AA, Offner H. Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice. Metab Brain Dis 2015;30:1117-27. [PMID: 25776868 DOI: 10.1007/s11011-015-9661-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
13 Obieglo K, Costain A, Webb LM, Ozir-Fazalalikhan A, Brown SL, MacDonald AS, Smits HH. Type I interferons provide additive signals for murine regulatory B cell induction by Schistosoma mansoni eggs. Eur J Immunol 2019;49:1226-34. [PMID: 31099896 DOI: 10.1002/eji.201847858] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sahin U, Tenzer S, Goebeler M, Kerstan A, Serfling E. NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells. Nat Commun 2016;7:11724. [PMID: 27222343 DOI: 10.1038/ncomms11724] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
15 Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol. 2013;10:122-132. [PMID: 23292280 DOI: 10.1038/cmi.2012.60] [Cited by in Crossref: 127] [Cited by in F6Publishing: 122] [Article Influence: 14.1] [Reference Citation Analysis]
16 Hoffmann F, Meinl E. B cells in multiple sclerosis: good or bad guys?: An article for 28 May 2014 - World MS Day 2014. Eur J Immunol 2014;44:1247-50. [PMID: 24771624 DOI: 10.1002/eji.201470045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
17 Nys J, Smulski CR, Tardivel A, Willen L, Kowalczyk C, Donzé O, Huard B, Hess H, Schneider P. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells. PLoS One 2013;8:e61350. [PMID: 23620746 DOI: 10.1371/journal.pone.0061350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
18 Mauri C, Menon M. Human regulatory B cells in health and disease: therapeutic potential. J Clin Invest 2017;127:772-9. [PMID: 28248202 DOI: 10.1172/JCI85113] [Cited by in Crossref: 197] [Cited by in F6Publishing: 130] [Article Influence: 39.4] [Reference Citation Analysis]
19 Xiao F, Lin X, Tian J, Wang X, Chen Q, Rui K, Ma J, Wang S, Wang Q, Wang X, Liu D, Sun L, Lu L. Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome. Cell Mol Immunol 2017. [PMID: 28690324 DOI: 10.1038/cmi.2017.8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
20 Gutiérrez C, Lopez-Abente J, Pérez-Fernández V, Prieto-Sánchez A, Correa-Rocha R, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M. Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients. PLoS One 2019;14:e0213744. [PMID: 30917149 DOI: 10.1371/journal.pone.0213744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Pattarabanjird T, Li C, McNamara C. B Cells in Atherosclerosis: Mechanisms and Potential Clinical Applications. JACC Basic Transl Sci 2021;6:546-63. [PMID: 34222726 DOI: 10.1016/j.jacbts.2021.01.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Afzali S, Salehi S, Shahi A, Amirzargar A. B cell modulation strategies in the improvement of transplantation outcomes. Mol Immunol 2020;125:140-50. [PMID: 32682148 DOI: 10.1016/j.molimm.2020.06.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Vadasz Z, Haj T, Kessel A, Toubi E. B-regulatory cells in autoimmunity and immune mediated inflammation. FEBS Lett. 2013;587:2074-2078. [PMID: 23707422 DOI: 10.1016/j.febslet.2013.05.023] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
24 Dufait I, Liechtenstein T, Lanna A, Bricogne C, Laranga R, Padella A, Breckpot K, Escors D. Retroviral and lentiviral vectors for the induction of immunological tolerance. Scientifica (Cairo) 2012;2012:694137. [PMID: 23526794 DOI: 10.6064/2012/694137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
25 Lühder F, Gold R. Trial and error in clinical studies: lessons from ATAMS. The Lancet Neurology 2014;13:340-1. [DOI: 10.1016/s1474-4422(14)70050-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
26 Hu Y, Wang J, Rao J, Xu X, Cheng Y, Yan L, Wu Y, Wu N, Wu X. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis. International Immunopharmacology 2020;80:106130. [DOI: 10.1016/j.intimp.2019.106130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Nguyen AL, Gresle M, Marshall T, Butzkueven H, Field J. Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. Br J Pharmacol 2017;174:1895-907. [PMID: 28319650 DOI: 10.1111/bph.13780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
28 Floudas A, Amu S, Fallon PG. New Insights into IL-10 Dependent and IL-10 Independent Mechanisms of Regulatory B Cell Immune Suppression. J Clin Immunol 2016;36:25-33. [DOI: 10.1007/s10875-016-0263-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
29 Tao L, Wang Y, Xu J, Su J, Yang Q, Deng W, Zou B, Tan Y, Ding Z, Li X. IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock. Pharmacol Res 2019;148:104457. [PMID: 31536782 DOI: 10.1016/j.phrs.2019.104457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kim JI, Rothstein DM, Markmann JF. Role of B cells in tolerance induction. Curr Opin Organ Transplant 2015;20:369-75. [PMID: 26107970 DOI: 10.1097/MOT.0000000000000204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
31 Mion F, Tonon S, Toffoletto B, Cesselli D, Pucillo CE, Vitale G. IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation. Molecular Immunology 2014;62:266-76. [DOI: 10.1016/j.molimm.2014.05.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
32 Stohl W. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2014;18:473-89. [DOI: 10.1517/14728222.2014.888415] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
33 Sanz I. Connective tissue diseases: targeting B cells in SLE: good news at last! Nat Rev Rheumatol 2011;7:255-6. [PMID: 21532638 DOI: 10.1038/nrrheum.2011.48] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
34 Menge T, Dubey D, Warnke C, Hartung H, Stüve O. Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis. Expert Review of Neurotherapeutics 2016;16:1131-9. [DOI: 10.1080/14737175.2016.1227242] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
35 Rosser EC, Mauri C. The emerging field of regulatory B cell immunometabolism. Cell Metab 2021;33:1088-97. [PMID: 34077716 DOI: 10.1016/j.cmet.2021.05.008] [Reference Citation Analysis]
36 Hsieh J, Williams P, Rafei M, Birman E, Cuerquis J, Yuan S, Wu J, Galipeau J. Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization. Mol Ther 2012;20:1767-77. [PMID: 22760541 DOI: 10.1038/mt.2012.127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Kong H, He J, Guo S, Song Q, Xiang D, Tao R, Yu H, Chen G, Huang Z, Ning Q, Huang J. Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells. PLoS Pathog 2020;16:e1008947. [PMID: 33075079 DOI: 10.1371/journal.ppat.1008947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Pfeuffer S, Ruck T, Kleinschnitz C, Wiendl H, Meuth SG. Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010–2015. Expert Review of Neurotherapeutics 2016;16:689-700. [DOI: 10.1080/14737175.2016.1176531] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
39 Subramanian S, Yates M, Vandenbark AA, Offner H. Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells. Immunology 2011;132:340-7. [PMID: 21091909 DOI: 10.1111/j.1365-2567.2010.03380.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
40 Gorosito Serrán M, Fiocca Vernengo F, Beccaria CG, Acosta Rodriguez EV, Montes CL, Gruppi A. The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production. FEBS Lett 2015;589:3362-9. [PMID: 26424657 DOI: 10.1016/j.febslet.2015.08.048] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
41 Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF, Fujimoto M. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood. 2013;121:3274-3283. [PMID: 23422748 DOI: 10.1182/blood-2012-11-465658] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 7.7] [Reference Citation Analysis]
42 Davidson A. Targeting BAFF in autoimmunity. Curr Opin Immunol 2010;22:732-9. [PMID: 20970975 DOI: 10.1016/j.coi.2010.09.010] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 6.0] [Reference Citation Analysis]
43 Engel P, Gómez-Puerta JA, Ramos-Casals M, Lozano F, Bosch X. Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacol Rev 2011;63:127-56. [PMID: 21245206 DOI: 10.1124/pr.109.002006] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
44 Mendez-Frausto G, Uresti-Rivera EE, Godina-Gonzalez S, Portales-Perez DP, Gonzalez-Amaro R, Garcia-Hernandez MH. Expression of mBD4, mBD3 and CRAMP during type II collagen-induced arthritis/CIA and their association with inflammation and bone-remodeling markers. Exp Mol Pathol 2021;123:104689. [PMID: 34592200 DOI: 10.1016/j.yexmp.2021.104689] [Reference Citation Analysis]
45 Levast B, Li Z, Madrenas J. The role of IL-10 in microbiome-associated immune modulation and disease tolerance. Cytokine 2015;75:291-301. [DOI: 10.1016/j.cyto.2014.11.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
46 Su J, Wang K, Zhou X, Wang Y, Xu J, Tao L, Zeng X, Chen N, Bai X, Li X. B-cell-specific-peroxisome proliferator-activated receptor γ deficiency augments contact hypersensitivity with impaired regulatory B cells. Immunology 2019;156:282-96. [PMID: 30471095 DOI: 10.1111/imm.13027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Bocian K, Kiernozek E, Domagała-Kulawik J, Korczak-Kowalska G, Stelmaszczyk-Emmel A, Drela N. Expanding Diversity and Common Goal of Regulatory T and B Cells. I: Origin, Phenotype, Mechanisms. Arch Immunol Ther Exp (Warsz) 2017;65:501-20. [PMID: 28477096 DOI: 10.1007/s00005-017-0469-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
48 Hua F, Ji L, Zhan Y, Li F, Zou S, Chen L, Gao S, Li Y, Chen H, Cheng Y. Aberrant frequency of IL-10-producing B cells and its association with Treg/Th17 in adult primary immune thrombocytopenia patients. Biomed Res Int 2014;2014:571302. [PMID: 25057496 DOI: 10.1155/2014/571302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
49 Matsushita T, Kobayashi T, Mizumaki K, Kano M, Sawada T, Tennichi M, Okamura A, Hamaguchi Y, Iwakura Y, Hasegawa M, Fujimoto M, Takehara K. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance. Sci Adv 2018;4:eaas9944. [PMID: 30009261 DOI: 10.1126/sciadv.aas9944] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 10.5] [Reference Citation Analysis]
50 Mohd Jaya FN, Garcia SG, Borràs FE, Chan GCF, Franquesa M. Paradoxical role of Breg-inducing cytokines in autoimmune diseases. J Transl Autoimmun 2019;2:100011. [PMID: 32743499 DOI: 10.1016/j.jtauto.2019.100011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
51 Ran Z, Yue-Bei L, Qiu-Ming Z, Huan Y. Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases. Front Immunol 2020;11:1884. [PMID: 32973780 DOI: 10.3389/fimmu.2020.01884] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
52 Moore-Connors JM, Kim HS, Marshall JS, Stadnyk AW, Halperin SA, Wang J. CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection. Mucosal Immunol 2015;8:94-106. [PMID: 24938746 DOI: 10.1038/mi.2014.45] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
53 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Smits HH. B cells in allergic diseases: Bad or Better? Autoimmunity 2012;45:415-26. [DOI: 10.3109/08916934.2012.665525] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
55 Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med. 2012;18:123-137. [PMID: 22033729 DOI: 10.2119/molmed.2011.00333] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 8.8] [Reference Citation Analysis]
56 Yang M, Deng J, Liu Y, Ko K, Wang X, Jiao Z, Wang S, Hua Z, Sun L, Srivastava G, Lau C, Cao X, Lu L. IL-10–Producing Regulatory B10 Cells Ameliorate Collagen-Induced Arthritis via Suppressing Th17 Cell Generation. The American Journal of Pathology 2012;180:2375-85. [DOI: 10.1016/j.ajpath.2012.03.010] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 11.7] [Reference Citation Analysis]
57 Sanaei MJ, Nahid-Samiei M, Abadi MSS, Arjmand MH, Ferns GA, Bashash D, Rahimian G, Bagheri N. New insights into regulatory B cells biology in viral, bacterial, and parasitic infections. Infect Genet Evol 2021;89:104753. [PMID: 33545392 DOI: 10.1016/j.meegid.2021.104753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Gu Y, Li K, Sun J, Zhang J. Characterization of CD19+ CD24hi CD38hi B cells in Chinese adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2020;34:2863-70. [PMID: 32242984 DOI: 10.1111/jdv.16399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Ray A, Mann MK, Basu S, Dittel BN. A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol 2011;230:1-9. [PMID: 21145597 DOI: 10.1016/j.jneuroim.2010.10.037] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
60 Lin X, Wang X, Xiao F, Ma K, Liu L, Wang X, Xu D, Wang F, Shi X, Liu D, Zhao Y, Lu L. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome. Cell Mol Immunol 2019;16:921-31. [PMID: 30948793 DOI: 10.1038/s41423-019-0227-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
61 Kappos L, Hartung HP, Freedman MS, Boyko A, Radü EW, Mikol DD, Lamarine M, Hyvert Y, Freudensprung U, Plitz T, van Beek J; ATAMS Study Group. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol 2014;13:353-63. [PMID: 24613349 DOI: 10.1016/S1474-4422(14)70028-6] [Cited by in Crossref: 195] [Cited by in F6Publishing: 94] [Article Influence: 24.4] [Reference Citation Analysis]
62 Clatworthy MR. B-cell regulation and its application to transplantation. Transpl Int 2014;27:117-28. [PMID: 23909582 DOI: 10.1111/tri.12160] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
63 Lin X, Deng J, Lu L. IL-10 detection in murine B cells: pros and cons of the different techniques. Methods Mol Biol 2014;1190:55-69. [PMID: 25015273 DOI: 10.1007/978-1-4939-1161-5_5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Krumbholz M, Meinl E. B cells in MS and NMO: pathogenesis and therapy. Semin Immunopathol 2014;36:339-50. [PMID: 24832354 DOI: 10.1007/s00281-014-0424-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 7.5] [Reference Citation Analysis]
65 Liu Z, Davidson A. BAFF inhibition: a new class of drugs for the treatment of autoimmunity. Exp Cell Res 2011;317:1270-7. [PMID: 21333645 DOI: 10.1016/j.yexcr.2011.02.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
66 Yang X, Yang J, Chu Y, Wang J, Guan M, Zhu X, Xue Y, Zou H. T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice. PLoS One 2013;8:e62855. [PMID: 23638156 DOI: 10.1371/journal.pone.0062855] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
67 Mion F, Benvenuti F, Pucillo C, Vitale G. Use of cocultures for the study of cellular interactions influencing B cell regulatory functions. Methods Mol Biol 2014;1190:163-79. [PMID: 25015280 DOI: 10.1007/978-1-4939-1161-5_12] [Reference Citation Analysis]
68 Bao Y, Liu X, Han C, Xu S, Xie B, Zhang Q, Gu Y, Hou J, Qian L, Qian C, Han H, Cao X. Identification of IFN-γ-producing innate B cells. Cell Res 2014;24:161-76. [PMID: 24296781 DOI: 10.1038/cr.2013.155] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
69 Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol. 2017;36:3-19. [PMID: 28215100 DOI: 10.1080/08830185.2016.1276903] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 12.6] [Reference Citation Analysis]
70 Hoffman W, Lakkis FG, Chalasani G. B Cells, Antibodies, and More. Clin J Am Soc Nephrol 2016;11:137-54. [PMID: 26700440 DOI: 10.2215/CJN.09430915] [Cited by in Crossref: 158] [Cited by in F6Publishing: 85] [Article Influence: 22.6] [Reference Citation Analysis]
71 Stożek K, Grubczak K, Marolda V, Eljaszewicz A, Moniuszko M, Bossowski A. Lower proportion of CD19 + IL-10 + and CD19 + CD24 + CD27 + but not CD1d + CD5 + CD19 + CD24 + CD27 + IL-10 + B cells in children with autoimmune thyroid diseases. Autoimmunity 2020;53:46-55. [DOI: 10.1080/08916934.2019.1697690] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
72 Sabatino JJ, Pröbstel A, Zamvil SS. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci 2019;20:728-45. [DOI: 10.1038/s41583-019-0233-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 23.3] [Reference Citation Analysis]
73 Sheng JR, Rezania K, Soliven B. Impaired regulatory B cells in myasthenia gravis. J Neuroimmunol 2016;297:38-45. [PMID: 27397074 DOI: 10.1016/j.jneuroim.2016.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
74 Xiang Y, Peng J, Tai N, Hu C, Zhou Z, Wong FS, Wen L. The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice. J Immunol 2012;188:4747-58. [PMID: 22490442 DOI: 10.4049/jimmunol.1103055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
75 Sim JH, Kim HR, Chang SH, Kim IJ, Lipsky PE, Lee J. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus. Arthritis Res Ther 2015;17:190. [PMID: 26209442 DOI: 10.1186/s13075-015-0687-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
76 Cho MJ, Ellebrecht CT, Payne AS. The dual nature of interleukin-10 in pemphigus vulgaris. Cytokine 2015;73:335-41. [PMID: 25464924 DOI: 10.1016/j.cyto.2014.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
77 Stanic B, van de Veen W, Wirz OF, Rückert B, Morita H, Söllner S, Akdis CA, Akdis M. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 2015;135:771-80.e8. [PMID: 25240783 DOI: 10.1016/j.jaci.2014.07.041] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 10.6] [Reference Citation Analysis]
78 Rizzo F, Giacomini E, Mechelli R, Buscarinu MC, Salvetti M, Severa M, Coccia EM. Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis. Immunol Cell Biol 2016;94:886-94. [PMID: 27265253 DOI: 10.1038/icb.2016.55] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
79 Jackson SW, Davidson A. BAFF inhibition in SLE-Is tolerance restored? Immunol Rev 2019;292:102-19. [PMID: 31562657 DOI: 10.1111/imr.12810] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
80 Baba Y, Matsumoto M, Kurosaki T. Signals controlling the development and activity of regulatory B-lineage cells. Int Immunol. 2015;27:487-493. [PMID: 25957265 DOI: 10.1093/intimm/dxv027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
81 Li W, Zhou M, Ren H, Hu HM, Lu L, Cao M, Wang LX. Tumor-derived autophagosomes (DRibbles) induce B cell activation in a TLR2-MyD88 dependent manner. PLoS One 2013;8:e53564. [PMID: 23326458 DOI: 10.1371/journal.pone.0053564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
82 Ren H, Zhang T, Wang Y, Yao Q, Wang Z, Zhang L, Wang L. Tumor-Derived Autophagosomes (DRibbles) Activate Human B Cells to Induce Efficient Antigen-Specific Human Memory T-Cell Responses. Front Immunol 2021;12:675822. [PMID: 34122437 DOI: 10.3389/fimmu.2021.675822] [Reference Citation Analysis]
83 Du W, Han M, Zhu X, Xiao F, Huang E, Che N, Tang X, Zou H, Jiang Q, Lu L. The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome. Front Immunol 2021;12:684999. [PMID: 34168653 DOI: 10.3389/fimmu.2021.684999] [Reference Citation Analysis]
84 Claes N, Fraussen J, Stinissen P, Hupperts R, Somers V. B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions. Front Immunol 2015;6:642. [PMID: 26734009 DOI: 10.3389/fimmu.2015.00642] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
85 Peñaloza HF, Schultz BM, Nieto PA, Salazar GA, Suazo I, Gonzalez PA, Riedel CA, Alvarez-Lobos MM, Kalergis AM, Bueno SM. Opposing roles of IL-10 in acute bacterial infection. Cytokine Growth Factor Rev 2016;32:17-30. [PMID: 27522641 DOI: 10.1016/j.cytogfr.2016.07.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
86 Krumbholz M, Derfuss T, Hohlfeld R, Meinl E. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 2012;8:613-23. [PMID: 23045237 DOI: 10.1038/nrneurol.2012.203] [Cited by in Crossref: 167] [Cited by in F6Publishing: 163] [Article Influence: 16.7] [Reference Citation Analysis]
87 Sigal LH. Basic science for the clinician 54: CD5. J Clin Rheumatol 2012;18:83-8. [PMID: 22334268 DOI: 10.1097/RHU.0b013e318247bc64] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
88 Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121:3645-3656. [PMID: 21821911 DOI: 10.1172/jci46274] [Cited by in Crossref: 324] [Cited by in F6Publishing: 183] [Article Influence: 29.5] [Reference Citation Analysis]
89 Tang Y, Jiang Q, Ou Y, Zhang F, Qing K, Sun Y, Lu W, Zhu H, Gong F, Lei P, Shen G. BIP induces mice CD19 hi regulatory B cells producing IL-10 and highly expressing PD-L1, FasL. Molecular Immunology 2016;69:44-51. [DOI: 10.1016/j.molimm.2015.10.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
90 Borhis G, Richard Y. Subversion of the B-cell compartment during parasitic, bacterial, and viral infections. BMC Immunol 2015;16:15. [PMID: 25884828 DOI: 10.1186/s12865-015-0079-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
91 Sheng JR, Quan S, Soliven B. CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis. J Immunol 2014;193:2669-77. [PMID: 25135828 DOI: 10.4049/jimmunol.1303397] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
92 Deng J, Liu Y, Yang M, Wang S, Zhang M, Wang X, Ko K, Hua Z, Sun L, Cao X, Lu L. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis & Rheumatism 2012;64:3564-73. [DOI: 10.1002/art.34637] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
93 Sakkas LI, Daoussis D, Mavropoulos A, Liossis SN, Bogdanos DP. Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases. Semin Arthritis Rheum. 2019;48:1133-1141. [PMID: 30409417 DOI: 10.1016/j.semarthrit.2018.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
94 Saraswathula A, Reap EA, Choi BD, Schmittling RJ, Norberg PK, Sayour EJ, Herndon JE 2nd, Healy P, Congdon KL, Archer GE, Sanchez-Perez L, Sampson JH. Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunol Immunother 2016;65:205-11. [PMID: 26759007 DOI: 10.1007/s00262-015-1784-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
95 Stolp J, Turka LA, Wood KJ. B cells with immune-regulating function in transplantation. Nat Rev Nephrol. 2014;10:389-397. [PMID: 24846332 DOI: 10.1038/nrneph.2014.80] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
96 Catalán D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguillón JC, Aravena O. Immunosuppressive Mechanisms of Regulatory B Cells. Front Immunol 2021;12:611795. [PMID: 33995344 DOI: 10.3389/fimmu.2021.611795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
97 Soares RR, Antinarelli LMR, Abramo C, Macedo GC, Coimbra ES, Scopel KKG. What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis? Pathog Glob Health 2017;111:107-15. [PMID: 28353409 DOI: 10.1080/20477724.2017.1308902] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
98 Song SS, Yuan PF, Li PP, Wu HX, Ni WJ, Lu JT, Wei W. Protective Effects of Total Glucosides of Paeony on N-nitrosodiethylamine-induced Hepatocellular Carcinoma in Rats via Down-regulation of Regulatory B Cells. Immunological Investigations 2015;44:521-35. [DOI: 10.3109/08820139.2015.1043668] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
99 Hu C, Li L. The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation. J Transl Med. 2019;17:412. [PMID: 31823784 DOI: 10.1186/s12967-019-02167-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
100 Rincón-Arévalo H, Sanchez-Parra CC, Castaño D, Yassin L, Vásquez G. Regulatory B Cells and Mechanisms. Int Rev Immunol 2016;35:156-76. [PMID: 25793964 DOI: 10.3109/08830185.2015.1015719] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
101 Vadasz Z, Peri R, Eiza N, Slobodin G, Balbir-Gurman A, Toubi E. The Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity. J Immunol Res 2015;2015:254245. [PMID: 26504851 DOI: 10.1155/2015/254245] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
102 Bae M, Kim H, Lim S, Lee S, Shin HS, Kim J, Im S, Kim S. Lactobacillus pentosus KF340 alleviates house dust mite-induced murine atopic dermatitis via the secretion of IL-10-producing splenic B10 cells. Journal of Functional Foods 2016;26:258-67. [DOI: 10.1016/j.jff.2016.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
103 Huang Y, Yang G, Fei J, Wu Y, Yan J. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1977-85. [PMID: 31950221 DOI: 10.1007/s00210-020-01817-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 van der Vlugt LE, Haeberlein S, de Graaf W, Martha TE, Smits HH. Toll-like receptor ligation for the induction of regulatory B cells. Methods Mol Biol 2014;1190:127-41. [PMID: 25015278 DOI: 10.1007/978-1-4939-1161-5_10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
105 Ma N, Zhang Y, Liu Q, Wang Z, Liu X, Zhu G, Yu D, Han G, Chen G, Hou C, Wang T, Ma Y, Shen B, Li Y, Xiao H, Wang R. B cell activating factor (BAFF) selects IL-10 − B cells over IL-10 + B cells during inflammatory responses. Molecular Immunology 2017;85:18-26. [DOI: 10.1016/j.molimm.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
106 Dang AK, Tesfagiorgis Y, Jain RW, Craig HC, Kerfoot SM. Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune Disease. Front Immunol 2015;6:470. [PMID: 26441975 DOI: 10.3389/fimmu.2015.00470] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
107 Morris-Rosenfeld S, Lipinski MJ, McNamara CA. Understanding the role of B cells in atherosclerosis: potential clinical implications. Expert Rev Clin Immunol 2014;10:77-89. [PMID: 24308836 DOI: 10.1586/1744666X.2014.857602] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
108 Zhang X. Regulatory functions of innate-like B cells. Cell Mol Immunol. 2013;10:113-121. [PMID: 23396472 DOI: 10.1038/cmi.2012.63] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 9.2] [Reference Citation Analysis]
109 Teague H, Fhaner CJ, Harris M, Duriancik DM, Reid GE, Shaikh SR. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity. J Lipid Res 2013;54:3130-8. [PMID: 23986558 DOI: 10.1194/jlr.M042457] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
110 Shao Y, Lo CM, Ling CC, Liu XB, Ng KT, Chu AC, Ma YY, Li CX, Fan ST, Man K. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Lett 2014;355:264-72. [PMID: 25301451 DOI: 10.1016/j.canlet.2014.09.026] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 7.5] [Reference Citation Analysis]
111 Axtell RC, Raman C. Janus-like effects of type I interferon in autoimmune diseases. Immunol Rev 2012;248:23-35. [PMID: 22725952 DOI: 10.1111/j.1600-065X.2012.01131.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
112 Vitale G, Mion F, Pucillo C. Regulatory B cells: evidence, developmental origin and population diversity. Mol Immunol. 2010;48:1-8. [PMID: 20950861 DOI: 10.1016/j.molimm.2010.09.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
113 Scholzen A, Sauerwein RW. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends in Parasitology 2013;29:252-62. [DOI: 10.1016/j.pt.2013.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
114 Ponnuswamy P, Joffre J, Herbin O, Esposito B, Laurans L, Binder CJ, Tedder TF, Zeboudj L, Loyer X, Giraud A, Zhang Y, Tedgui A, Mallat Z, Ait-Oufella H. Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells. Sci Rep 2017;7:4111. [PMID: 28646220 DOI: 10.1038/s41598-017-04438-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
115 Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11:34-46. [PMID: 21151033 DOI: 10.1038/nri2901] [Cited by in Crossref: 598] [Cited by in F6Publishing: 557] [Article Influence: 49.8] [Reference Citation Analysis]
116 So BYF, Yap DYH, Chan TM. B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management. Int J Mol Sci 2021;22:13560. [PMID: 34948358 DOI: 10.3390/ijms222413560] [Reference Citation Analysis]
117 Baker KF, Isaacs JD. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? Ann Rheum Dis 2018;77:175-87. [PMID: 28765121 DOI: 10.1136/annrheumdis-2017-211555] [Cited by in Crossref: 159] [Cited by in F6Publishing: 141] [Article Influence: 31.8] [Reference Citation Analysis]
118 Zheng Z, Liu T, Li X, Ding J, Feng Y, Miao J, Luo X, Wu Z, Zhu P. Kinetic changes of regulatory B10 cells in collagen-induced arthritis could be regulated by cytokines IFN-γ and TGF-β1. Inflamm Res 2015;64:637-45. [DOI: 10.1007/s00011-015-0846-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
119 Wąsik M, Nazimek K, Bryniarski K. Regulatory B cell phenotype and mechanism of action: the impact of stimulating conditions. Microbiol Immunol 2018;62:485-96. [PMID: 29998521 DOI: 10.1111/1348-0421.12636] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
120 Beaudette-Zlatanova BC, Le PT, Knight KL, Zhang S, Zakrzewski S, Parthasarathy M, Stiff PJ. A potential role for B cells in suppressed immune responses in cord blood transplant recipients. Bone Marrow Transplant 2013;48:85-93. [PMID: 22732699 DOI: 10.1038/bmt.2012.104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
121 Garraud O, Borhis G, Badr G, Degrelle S, Pozzetto B, Cognasse F, Richard Y. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol 2012;13:63. [PMID: 23194300 DOI: 10.1186/1471-2172-13-63] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
122 Liu J, Liu Q, Chen X. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells. Front Immunol 2020;11:1843. [PMID: 32922398 DOI: 10.3389/fimmu.2020.01843] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
123 Menon M, Hussell T, Ali Shuwa H. Regulatory B cells in respiratory health and diseases. Immunol Rev 2021;299:61-73. [PMID: 33410165 DOI: 10.1111/imr.12941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
124 Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 2016;30:163-72. [PMID: 26139429 DOI: 10.1038/leu.2015.174] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
125 Haeberlein S, Obieglo K, Ozir-Fazalalikhan A, Chayé MAM, Veninga H, van der Vlugt LEPM, Voskamp A, Boon L, den Haan JMM, Westerhof LB, Wilbers RHP, Schots A, Schramm G, Hokke CH, Smits HH. Schistosome egg antigens, including the glycoprotein IPSE/alpha-1, trigger the development of regulatory B cells. PLoS Pathog 2017;13:e1006539. [PMID: 28753651 DOI: 10.1371/journal.ppat.1006539] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
126 Wang K, Tao L, Su J, Zhang Y, Zou B, Wang Y, Zou M, Chen N, Lei L, Li X. TLR4 supports the expansion of FasL+CD5+CD1dhi regulatory B cells, which decreases in contact hypersensitivity. Mol Immunol 2017;87:188-99. [PMID: 28505514 DOI: 10.1016/j.molimm.2017.04.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
127 Mauri C. Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 2010;22:761-7. [PMID: 21087847 DOI: 10.1016/j.coi.2010.10.009] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
128 Kim HS, Lee JH, Han HD, Kim AR, Nam ST, Kim HW, Park YH, Lee D, Lee MB, Park YM. Autocrine stimulation of IL-10 is critical to the enrichment of IL-10-producing CD40(hi)CD5(+) regulatory B cells in vitro and in vivo. BMB Rep. 2015;48:54-59. [PMID: 25341924 DOI: 10.5483/bmbrep.2015.48.1.213] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
129 Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017;74:2345-2360. [PMID: 28214990 DOI: 10.1007/s00018-017-2473-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 16.0] [Reference Citation Analysis]
130 Wu L, Parekh VV, Hsiao J, Kitamura D, Van Kaer L. Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance. Proc Natl Acad Sci U S A 2014;111:E4638-47. [PMID: 25313053 DOI: 10.1073/pnas.1324052111] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
131 Valizadeh A, Sanaei R, Rezaei N, Azizi G, Fekrvand S, Aghamohammadi A, Yazdani R. Potential role of regulatory B cells in immunological diseases. Immunol Lett 2019;215:48-59. [PMID: 31442542 DOI: 10.1016/j.imlet.2019.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
132 Vonberg AD, Acevedo-Calado M, Cox AR, Pietropaolo SL, Gianani R, Lundy SK, Pietropaolo M. CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus. JCI Insight 2018;3:99860. [PMID: 30518692 DOI: 10.1172/jci.insight.99860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Pröbstel AK, Sanderson NS, Derfuss T. B Cells and Autoantibodies in Multiple Sclerosis. Int J Mol Sci 2015;16:16576-92. [PMID: 26197319 DOI: 10.3390/ijms160716576] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
134 Dalloul A. B-cell-mediated strategies to fight chronic allograft rejection. Front Immunol 2013;4:444. [PMID: 24381571 DOI: 10.3389/fimmu.2013.00444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
135 Zhu Q, Rui K, Wang S, Tian J. Advances of Regulatory B Cells in Autoimmune Diseases. Front Immunol 2021;12:592914. [PMID: 33936028 DOI: 10.3389/fimmu.2021.592914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Croft M, Benedict CA, Ware CF. Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov. 2013;12:147-168. [PMID: 23334208 DOI: 10.1038/nrd3930] [Cited by in Crossref: 242] [Cited by in F6Publishing: 220] [Article Influence: 26.9] [Reference Citation Analysis]
137 Bouma G, Carter NA, Recher M, Malinova D, Adriani M, Notarangelo LD, Burns SO, Mauri C, Thrasher AJ. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells. Eur J Immunol 2014;44:2692-702. [PMID: 24945741 DOI: 10.1002/eji.201344245] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
138 Fehres CM, van Uden NO, Yeremenko NG, Fernandez L, Franco Salinas G, van Duivenvoorde LM, Huard B, Morel J, Spits H, Hahne M, Baeten DLP. APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1. Front Immunol 2019;10:1368. [PMID: 31258536 DOI: 10.3389/fimmu.2019.01368] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
139 Amrouche K, Jamin C. Influence of drug molecules on regulatory B cells. Clinical Immunology 2017;184:1-10. [DOI: 10.1016/j.clim.2017.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
140 Komlósi ZI, Kovács N, van de Veen W, Kirsch AI, Fahrner HB, Wawrzyniak M, Rebane A, Stanic B, Palomares O, Rückert B, Menz G, Akdis M, Losonczy G, Akdis CA. Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL-10–producing immature transitional regulatory B cells. Journal of Allergy and Clinical Immunology 2018;142:178-194.e11. [DOI: 10.1016/j.jaci.2017.07.046] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
141 Porsch F, Binder CJ. Impact of B-Cell–Targeted Therapies on Cardiovascular Disease. ATVB 2019;39:1705-14. [DOI: 10.1161/atvbaha.119.311996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
142 Alexandrakis MG, Roussou P, Pappa CA, Messaritakis I, Xekalou A, Goulidaki N, Boula A, Tsirakis G. Relationship between circulating BAFF serum levels with proliferating markers in patients with multiple myeloma. Biomed Res Int 2013;2013:389579. [PMID: 23936794 DOI: 10.1155/2013/389579] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
143 Wang R, Wang R, Ma N, Guo Y, Xiao H, Chen G, Han G, Hou C, Shen B, Feng J, Li Y. Identify the key amino acid of BAFF binding with TACI. Cell Immunol 2013;284:84-90. [PMID: 23954794 DOI: 10.1016/j.cellimm.2013.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
144 Chhabra M, Conlon TM, Saeb-parsy K, Pettigrew GJ. BAFF and Associated TNF Superfamily Members in Renal Transplantation: An End to BLySful Ignorance. Transplantation 2013;96:853-9. [DOI: 10.1097/tp.0b013e3182997d34] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
145 Godahewa G, Perera N, Umasuthan N, Wan Q, Whang I, Lee J. Molecular characterization and expression analysis of B cell activating factor from rock bream (Oplegnathus fasciatus). Developmental & Comparative Immunology 2016;55:1-11. [DOI: 10.1016/j.dci.2015.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
146 Kim J, Lee HJ, Yoo IS, Kang SW, Lee JH. Regulatory B cells are inversely associated with disease activity in rheumatoid arthritis. Yonsei Med J 2014;55:1354-8. [PMID: 25048496 DOI: 10.3349/ymj.2014.55.5.1354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
147 Mariño E, Silveira PA, Stolp J, Grey ST. B cell-directed therapies in type 1 diabetes. Trends Immunol 2011;32:287-94. [PMID: 21531625 DOI: 10.1016/j.it.2011.03.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
148 Zheng Y, Guo Z, He W, Yang Y, Li Y, Zheng A, Li P, Zhang Y, Ma J, Wen M, Yang M, An H, Ji G, Yu Y. Ephedrine hydrochloride protects mice from LPS challenge by promoting IL-10 secretion and inhibiting proinflammatory cytokines. Int Immunopharmacol 2012;13:46-53. [PMID: 22446503 DOI: 10.1016/j.intimp.2012.03.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
149 Poudrier J, Chagnon-Choquet J, Roger M. Influence of dendritic cells on B-cell responses during HIV infection. Clin Dev Immunol 2012;2012:592187. [PMID: 22461837 DOI: 10.1155/2012/592187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
150 Smets I, Prezzemolo T, Imbrechts M, Mallants K, Mitera T, Humblet-Baron S, Dubois B, Matthys P, Liston A, Goris A. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis. Front Immunol 2021;12:676619. [PMID: 34122439 DOI: 10.3389/fimmu.2021.676619] [Reference Citation Analysis]
151 Ryan GA, Wang CJ, Chamberlain JL, Attridge K, Schmidt EM, Kenefeck R, Clough LE, Dunussi-Joannopoulos K, Toellner KM, Walker LS. B1 cells promote pancreas infiltration by autoreactive T cells. J Immunol 2010;185:2800-7. [PMID: 20675587 DOI: 10.4049/jimmunol.1000856] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
152 Hayashi M, Yanaba K, Umezawa Y, Yoshihara Y, Kikuchi S, Ishiuji Y, Saeki H, Nakagawa H. IL-10-producing regulatory B cells are decreased in patients with psoriasis. Journal of Dermatological Science 2016;81:93-100. [DOI: 10.1016/j.jdermsci.2015.11.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
153 Zhang Y, Tian J, Xiao F, Zheng L, Zhu X, Wu L, Zhao C, Wang S, Rui K, Zou H, Lu L. B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews 2021. [DOI: 10.1016/j.cytogfr.2021.11.004] [Reference Citation Analysis]
154 Baba Y, Saito Y, Kotetsu Y. Heterogeneous subsets of B-lineage regulatory cells (Breg cells). Int Immunol 2020;32:155-62. [PMID: 31630184 DOI: 10.1093/intimm/dxz068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
155 Borsum N, Verboom M, Ahlenstiel-Grunow T, Pape L. Cytokine Profiles in Children After Pediatric Kidney Transplantation With Acute Cellular Compared to Chronic Antibody-mediated Rejection and Stable Patients: A Pilot Study. Transplant Direct 2019;5:e501. [PMID: 31773054 DOI: 10.1097/TXD.0000000000000943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
156 Berthelot JM, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P. Regulatory B cells play a key role in immune system balance. Joint Bone Spine. 2013;80:18-22. [PMID: 22858147 DOI: 10.1016/j.jbspin.2012.04.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
157 Klein da Costa B, Brant de Souza Melo R, Passos GRD, Gomes Meneses Sevilha Castro D, Becker J, Bar-Or A, Sato DK. Unraveling B lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets. Neurology 2020;95:733-44. [PMID: 32907966 DOI: 10.1212/WNL.0000000000010789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
158 Calle CL, Mordmüller B, Singh A. Immunosuppression in Malaria: Do Plasmodium falciparum Parasites Hijack the Host? Pathogens 2021;10:1277. [PMID: 34684226 DOI: 10.3390/pathogens10101277] [Reference Citation Analysis]
159 Sakai J, Akkoyunlu M. The Role of BAFF System Molecules in Host Response to Pathogens. Clin Microbiol Rev 2017;30:991-1014. [PMID: 28855265 DOI: 10.1128/CMR.00046-17] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
160 Lin X, Lu L. B Cell-Mediated Autoimmune Diseases. Adv Exp Med Biol 2020;1254:145-60. [PMID: 32323275 DOI: 10.1007/978-981-15-3532-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Poudrier J, Roger M. Dendritic cell status modulates the outcome of HIV-related B cell disease progression. PLoS Pathog 2011;7:e1002154. [PMID: 21901089 DOI: 10.1371/journal.ppat.1002154] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
162 Durand J, Chiffoleau E. B cells with regulatory properties in transplantation tolerance. World J Transplant 2015; 5(4): 196-208 [PMID: 26722647 DOI: 10.5500/wjt.v5.i4.196] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
163 Bhise V, Dhib-Jalbut S. Further understanding of the immunopathology of multiple sclerosis: impact on future treatments. Expert Rev Clin Immunol 2016;12:1069-89. [PMID: 27191526 DOI: 10.1080/1744666X.2016.1191351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
164 Margry B, Kersemakers SC, Hoek A, Arkesteijn GJ, Wieland WH, van Eden W, Broere F. Activated peritoneal cavity B-1a cells possess regulatory B cell properties. PLoS One 2014;9:e88869. [PMID: 24551182 DOI: 10.1371/journal.pone.0088869] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
165 Doherty DG, Melo AM, Moreno-Olivera A, Solomos AC. Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells. Front Immunol 2018;9:1360. [PMID: 29967611 DOI: 10.3389/fimmu.2018.01360] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
166 Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, Smits HH. Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011;128:733-9. [PMID: 21684587 DOI: 10.1016/j.jaci.2011.05.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 7.7] [Reference Citation Analysis]
167 Li R, Sun X, Liu X, Yang Y, Li Z. Autoimmune diseases in China. Adv Immunol 2019;144:173-216. [PMID: 31699217 DOI: 10.1016/bs.ai.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
168 San Segundo D, López-hoyos M, Arias M. Regulatory B-Cells in Transplantation. Antibodies 2013;2:587-97. [DOI: 10.3390/antib2040587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
169 Koneczny I, Yilmaz V, Lazaridis K, Tzartos J, Lenz TL, Tzartos S, Tüzün E, Leypoldt F. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common? Front Immunol 2020;11:605214. [PMID: 33584677 DOI: 10.3389/fimmu.2020.605214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
170 Qian L, Qian C, Chen Y, Bai Y, Bao Y, Lu L, Cao X. Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L. Blood 2012;120:581-91. [PMID: 22692512 DOI: 10.1182/blood-2011-08-377242] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
171 Ding T, Su R, Wu R, Xue H, Wang Y, Su R, Gao C, Li X, Wang C. Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells. Front Immunol 2021;12:641013. [PMID: 33841422 DOI: 10.3389/fimmu.2021.641013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
172 Sabatino JJ Jr, Zamvil SS, Hauser SL. B-Cell Therapies in Multiple Sclerosis. Cold Spring Harb Perspect Med 2019;9:a032037. [PMID: 29358322 DOI: 10.1101/cshperspect.a032037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
173 Madhuranga W, Tharuka MN, Yang H, Lim C, Wan Q, Bathige S, Lee J. Molecular expression analysis and characterization of rockfish (Sebastes schlegelii) B cell activating factor. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2020;250:110480. [DOI: 10.1016/j.cbpb.2020.110480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]